Metabolomic and lipidomic studies measure and discover metabolic and lipid profiles in biological samples, enabling a better understanding of the metabolism of specific biological phenotypes. accurate biological interpretations require high analytical reproducibility and sensitivity, and standardized and transparent data processing. Here we describe a complete workflow for nanoelectrospray ionization (nesI) direct-infusion mass spectrometry (DIMs) metabolomics and lipidomics. after metabolite and lipid extraction from tissues and biofluids, samples are directly infused into a high-resolution mass spectrometer (e.g., orbitrap) using a chip-based nesI sample delivery system. nesI functions to minimize ionization suppression or enhancement effects as compared with standard electrospray ionization (esI). our analytical technique-named spectral stitching-measures data as several overlapping mass-to-charge (m/z) windows that are subsequently 'stitched' together, creating a complete mass spectrum. this considerably increases the dynamic range and detection sensitivity-about a fivefold increase in peak detection-as compared with the collection of DIMs data as a single wide mass-to-charge (m/z ratio) window. Data processing, statistical analysis and metabolite annotation are executed as a workflow within the user-friendly, transparent and freely available Galaxy platform (galaxyproject.org). Generated data have high mass accuracy that enables molecular formulae peak annotations. the workflow is compatible with any sample-extraction method; in this protocol, the examples are extracted using a biphasic method, with methanol, chloroform and water as the solvents. the complete workflow is reproducible, rapid and automated, which enables cost-effective analysis of >10,000 samples per year, making it ideal for high-throughput metabolomics and lipidomics screening-e.g., for clinical phenotyping, drug screening and toxicity testing.
IntroDuctIon
Nontargeted metabolomics and lipidomics techniques comprise the measurement and analysis of the steady-state levels of the multiple metabolites or lipids (termed the metabolome or lipidome) within biological samples [1] [2] [3] [4] . Comparison of the metabolome or lipidome across different phenotypes represents a powerful and unbiased approach for discovering molecular perturbations that can in turn be used to generate biological hypotheses for more detailed investigation. This approach is applicable to diverse sample types, including biofluids 5, 6 , mammalian cells 7 and spent cell media 8 , tissues 9 and whole organisms 10 , as well as to a wide range of biological questions such as the investigation of disease 9 , drug action 7 and toxicology 11 . Metabolites and lipids have many diverse functions in biological systems. They are typically the end products of complex cellular regulation networks 1 (at the genetic, epigenetic, transcriptional, translational and posttranslational levels), and they can also influence and alter this regulation via feedback loops 12 , protein modifications 13 and epigenetic changes 14 . They are both building blocks of complex cellular macromolecules and sources and intermediates in energy metabolism. Thus, metabolomics and lipidomics analyses can give insightful knowledge of the functional molecular status of biological systems (e.g., energetic status and the balance of anabolic and catabolic processes) and can complement other 'omic technologies as well as traditional molecular biological investigations.
To accurately and reliably interpret data derived from metabolomics and lipidomics studies, the entire workflow, including the experimental design, sample collection and extraction, as well as data acquisition, processing, metabolite identification and statistical analysis, should be robust and reproducible. High detection sensitivity of the chosen analytical approach is also desirable. The most common analytical techniques used in metabolomics include NMR spectroscopy and mass spectrometry (MS) 15 . Although NMR is highly quantitative and reproducible, MS methods are increasingly favored for metabolomics and lipidomics because of their higher sensitivity 15, 16 . MS approaches often include chromatographic separation, which serves to resolve the complex mixture of metabolites or lipids before ion detection, thereby helping to distinguish between isobaric compounds and to minimize ionization suppression (or enhancement) effects. It is because of these attributes that gas chromatography MS 17 and liquid chromatography (LC) MS 18 , and to a lesser extent capillary electrophoresis MS 19 and ion chromatography MS 20 , are popular and widely used for metabolomics and lipidomics investigations. DIMS is an alternative approach involving the direct introduction of biological extracts into MS systems without any prior chromatographic separation 21 . Nominal-mass, flow-injection ESI DIMS approaches have previously been developed and successfully applied to highthroughput metabolomics 22 . However, substantially higher-quality DIMS data can be acquired by using automated nESI sample delivery platforms in combination with ultra-high mass resolution and accuracy MS detectors (e.g., Fourier transform ion cyclotron resonance (FT-ICR) MS, Orbitrap MS) 10, 23, 24 . These platforms increase the number of detectable peaks by minimizing ionization suppression and enhancement effects (relative to ESI) 25 . They also maximize the discrimination of peaks with similar accurate masses, thereby facilitating more accurate molecular formula(e) peak annotations of the data 26 .
The protocol described here is a complete workflow for conducting high-resolution nESI DIMS metabolomics and lipidomics investigations ( Fig. 1) , guided by the Metabolomics Standards Initiative framework 27 . The optimized nESI DIMS method, termed 'spectral-stitching nESI DIMS' , collects MS data as a series of overlapping m/z windows that are subsequently stitched together into a complete spectrum ( Fig. 2; Table 1 ). This approach maximizes both the quantity and mass accuracy of detectable peaks 23, 24 . The automated data processing and analysis steps are collated into an open-source workflow within Galaxy 28 . This offers a standardized, transparent and user-friendly approach without the requirement for bioinformatics expertise and knowledge of multiple programming languages and/or environments. Galaxy is an open-source workflow platform that is used for next-generation sequencing data analysis. It has many standard processing tools (accessible from its web-based user interface) that improve both the speed and reproducibility of data processing and analysis.
Our recent development of the Galaxy-M spectral-stitching nESI DIMS workflow considerably increases the accessibility of the spectral-stitching nESI DIMS metabolomics approach 28 .
Advantages and limitations of the spectral-stitching nESI DIMS workflow
A major advantage of the spectral-stitching nESI DIMS workflow is the generation of high-quality metabolomics or lipidomics data, with high spectral resolution, mass accuracy and dynamic range, in a short time frame and in a cost-effective manner. The high resolution and mass accuracy allow for the accurate annotation of peaks with molecular formula(e) and for compounds with similar masses to be resolved 23, 26 , which is particularly advantageous when analyzing complex mixtures of chemicals. Spectral-stitching nESI DIMS increases detection sensitivity fivefold as compared with standard wide-scan DIMS (for a constant number of ions entering the detector at each scan) 23 and is highly reproducible: the median relative standard deviation (RSD) of peak intensities in 80 repeated injections of the same biological sample was 8.2% (ref. 29) . The intensity measurements are robust and correlate well with peak intensities measured using quantitative NMR methods for selected metabolites 11, 30 , demonstrating the high relative-quantification capability of the method (see ANTICIPATED RESULTS). In addition, DIMS has been suggested to have metabolomic classification and prediction capabilities comparable to those of LC-MS 31 . DIMS is more applicable to lipidomics than is NMR because of the highly congested lipid region in 1 H NMR spectra, and the higher sensitivity of DIMS as compared with NMR is a clear advantage for both metabolomics and lipidomics. As compared with chromatography-based MS, DIMS approaches-including the spectralstitching method-have considerably shorter acquisition times (enabling higher throughput); no chromatographic drift (as observed for LC-MS as the column ages), enabling more robust alignment of multiple spectra; no carry-over between biological samples; and lower consumables costs.
The spectral-stitching nESI DIMS workflow is a global profiling method, and therefore it cannot detect all metabolites or lipids in a single experiment. For the analysis of specific metabolites or lipids, extraction procedures that are designed to maximize these compound classes should be used before DIMS data collection. A limitation of DIMS is ion suppression or ion enhancement, which are caused by multiple different compounds entering the ionization source at the same time 32 . However, the low flow rate associated with nESI, as used here, minimizes these artifacts 25, 33 . Sample lipid concentration can vary between sample types. To prevent highly abundant lipids from dominating the DIMS analysis, a dilution study is required to find the optimal sample dilution (see 'Resuspension of biological sample extracts in DIMS solvents' in the protocol below)-a sample lipid concentration of <10 pmol/µl is recommended 34 . The limitations of DIMS as compared with chromatography-based MS or NMR techniques include the inability to resolve isobaric compounds and the inability to provide any structural information on compounds unless further MS/MS analyses are conducted. However, it is typically very difficult to isolate just the ion of interest for DIMS/MS, given the complexity of the mass spectra 11 . A further limitation of DIMS is the relative-quantitative nature of the measurement-i.e., as for LC-MS metabolomics, it measures relative fold-changes between biological samples. In comparison, NMR can be regarded as fully quantitative, and LC-MS/MS using internal standards is also quantitative, albeit just for selected peaks of interest. If desired, these approaches can be used to fully quantify metabolites that are discovered to be important by the spectral-stitching nESI DIMS method workflow. Therefore, DIMS, chromatography-based MS and NMR each possess different advantages and limitations, and act as complementary approaches for metabolomics and lipidomics, depending upon the analyst's requirements.
Applications of the spectral-stitching nESI DIMS workflow
The spectral-stitching nESI DIMS workflow is ideal for large-scale discovery studies 29 . It has successfully been applied to a diverse range of biological sample types, including tissues 11 , mammalian cells 7 , whole-organism homogenates 10 and hemolymph 35 , and is also applicable to urine 36 , serum 31 and plasma analysis 37 . Furthermore, it has been used to investigate a broad range of biological questions, including studies of xenobiotic toxicity in whole organisms 10 and in specific organs 11, 38 ; identification of metabolic changes associated with disease 39 ; elucidation of the action of therapeutic drugs on the lipidome of human leukemia cells 7 ; and metabolic footprinting analysis to understand the interactions of algae with their environment 40 . The high resolution of the MS detector means that this workflow is also compatible with 13 C-labeling 'pulse-chase' or 'flux' approaches, wherein the metabolism and fate of a 13 C-labeled substrate such as 13 C-glucose or 13 C-glutamine is measured as a function of time-e.g., measurement of 13 C-glucose incorporation into fatty acids and phospholipids in response to drug treatments 7 .
A further example of the application of this DIMS workflow is that of the classification of compounds as being of endogenous, exogenous or metabolized-exogenous origin, following exposure of an organism to an undefined chemical mixture, by analyzing both the organism's tissue and the exposome 41 . Given that metabolomics has now matured to a widely used, relatively stable analytical and computational approach, with a rapidly growing community supported by a wide range of training opportunities for researchers, the field is now poised to tackle very-largescale challenges in the biomedical and regulatory sciences. As one example, regulatory toxicology is now opening the door to new testing strategies for determining the impacts of chemicals on human health. Given that there are approaching 100,000 chemicals used in industry and consumer products, the need for veryhigh-throughput screening approaches, incorporating 'omics' data generation, are paramount. The protocol reported here is an important step toward translating metabolomics into regulatory toxicology 42, 43 . Experimental design A well-designed experiment is essential to ensuring a meaningful and robust outcome to a DIMS study. Biological sample collection, preparation and nESI DIMS data generation must be randomized across sample classes (typically different biological phenotypes) to prevent user-induced bias. The amount of biological replication required to provide adequate statistical power to the study will be influenced by the type of experiment being conducted. On the basis of a decade of expertise, our recommended levels of biological replication vary from n = 6 (for well-controlled laboratory-based studies with relatively little intersample biological variance, such as nESI DIMS of mammalian cell culture extracts) to n = 10 (controlled laboratory studies but with greater biological variance, such as model organism studies) to larger n values for cases in which biological variance is not controlled (clinical and environmental biological samples). With pilot data, this estimation can be improved by applying sample size and power analyses (MetaboAnalyst 3.0, http://www.metaboanalyst.ca). Technical replication should also be included in the nESI DIMS workflow as a method for distinguishing peaks of biological origin from background noise, increasing the accuracy of the intensity measurements and allowing for an estimation of the reproducibility of peak intensity measurements 44 (see the 'Data processing' section, below).
To distinguish peaks of biological origin from genuine but nonbiological peaks, such as those that may arise from the sample preparation method (i.e., from solvents and/or contaminants), an 'extract blank' (sample preparation procedure conducted in the absence of a biological sample) should also be prepared and analyzed. Quality control (QC) samples are a critical component of both the nESI DIMS experimental design and data QC (see 'Data QC' section, below). Internal QC samples should be derived by pooling a small volume of ideally all biological samples within one metabolomics study, and then analyzing them at regular intervals throughout the analytical run-e.g., every fifth or sixth DIMS analysis is of a QC sample. Internal QC samples are used to monitor and correct for slight analytical variance between samples acquired through one or more analytical batches within that one study (see the signal correction algorithm, 'Data processing' section). External QC samples (i.e., using a surrogate sample) can be used to monitor and correct for analytical variance between different metabolomics studies.
Biological sample collection, storage and preparation
The time between biological sample collection and freezing should be as short as possible in order to rapidly halt enzymatic activity and cease changes to the metabolome or lipidome. For mammalian cell culture, a quenching approach is used, in which cells are sampled directly into a quenching solution (such as −40 °C aqueous methanol) 7, 45 . For the collection of small model organisms (e.g., Daphnia and Drosophila) 46 , tissue from larger organisms 47 and biofluids (e.g., urine 48 , serum 49 or plasma 49 ), we refer the reader to the appropriate specialist literature. Biological samples must remain frozen at −80 °C until extraction of the metabolites and/or lipids. Preparation of solid biological samples typically involves their physical disruption (by a homogenization probe-e.g., Polytronor a bead-based homogenizer-e.g., Precellys 24 (ref. 50) ) in the presence of solvents to simultaneously extract the polar metabolites and/or lipids into a liquid phase while denaturing the metabolic enzymes to halt any further changes to the metabolome or lipidome 50, 51 . For serum, plasma 49 and mammalian cell suspensions 7 , vortex-mixing in the presence of the extraction solvent is sufficient to denature the enzymes and to extract the metabolites and/or lipids. Urine can be more simply prepared by centrifugation and dilution with water because of its very low protein (and therefore very low enzyme) content 48 . Extraction techniques should be reproducible-i.e., introduce minimal technical variation to the study-and should achieve as high a yield of metabolites and/or lipids as possible. Several solvent systems can be used 50, 51 . Fine adjustments to the extraction conditions, e.g., pH and solvent polarity, can be used to extract specific classes of compounds according to their solubility characteristics 52 . Biphasic extraction methods use immiscible solvents to simultaneously extract polar metabolites and lipids into separate phases 50, 51, 53, 54 . This reduces biological sample complexity, which is advantageous for (non-chromatography-based) nESI DIMS. Our optimized biphasic extraction-based on a procedure developed by Bligh and Dyer 53 -uses a methanol:chloroform:water ratio of 2:2:1.8 to maximize metabolite yield, metabolic sample stability and reproducibility 50 . Alternatively, the use of methyl tert-butyl ether, methanol and water is an increasingly popular biphasic approach for lipidomics that improves the extraction of some lipid classes (e.g., ceramides) as compared with the Bligh and Dyer method 54 .
After extraction, extracts should be dried to maintain stability and, subsequently, to enable resuspension in appropriate solvents for DIMS; note that lipids must be dried and stored under nitrogen to prevent oxidative lipid damage, whereas polar metabolites in an aqueous methanol solution are more typically dried using a vacuum centrifugation system such as the SpeedVac concentrator.
Direct-infusion mass spectrometry
Sample ionization and analytical detection methods can strongly influence the quality of DIMS metabolomics and lipidomics data. ESI, a soft-ionization technique, is particularly appropriate for DIMS, as it can predominantly ionize the metabolites and/or lipids as intact compounds 16 , aiding compound molecular formula(e) annotations. A very low flow rate through the electrospray ionization source is essential for minimizing both ionization suppression and enhancement effects 25, 33 ; our nanoflow ESI methods typically use a flow rate of 200-300 nl/min, as compared with the several-microliters-per-minute rates used for standard ESI sources. nESI also benefits from lower sample volume requirements and considerably higher sensitivity 55 . To aid nESI compound ionization, a modifying agent is typically added to the solubilized biological sample (e.g., formic acid or ammonium acetate), which will also influence the types of ion forms that are created (see the 'Peak annotation' section, below). High lipid concentrations in samples can lead to aggregate formation (e.g., dimers) during DIMS analysis 34 . This can be prevented by keeping lipid concentrations <10 pmol/µl when using a 2:1 methanol:chloroform ratio 34 . For high-throughput metabolomics and lipidomics, an automated chip-based nESI source (e.g., Advion TriVersa NanoMate) enables rapid, reproducible and automated acquisition of multiple biological samples without sample-to-sample cross-contamination 25, 55 .
Ultra-high-resolution, high-mass-accuracy detectors (e.g., the Orbitrap series of mass spectrometers and FT-ICR, both with a resolution capable of exceeding 100K at a m/z value of 200) are ideal for DIMS as they resolve peaks with similar accurate masses and allow for the annotation of peaks with molecular formula(e). This increases the coverage of the metabolome or lipidome and enhances annotation confidence as compared with lower-resolution, lower-mass-accuracy instruments. For Thermo Scientific Orbitrap series and FT-ICR mass spectrometers, the number of ions entering the detector is controlled by the Automatic Gain Control (AGC). The number of ions within the detector is approximately proportional to detection sensitivity; however, if the number of ions is too high, then the mass accuracy decreases (due to space-charge effects 56 ), ultimately making unique molecular formula(e) annotation impossible. This is particularly problematic when collecting DIMS data over a single large m/z range (e.g., 100-1,000 m/z), for which a higher AGC setting is required to capture and then detect the lower-abundance compounds. A proven solution to this is provided by the spectral-stitching nESI method, in which data are collected as a series of overlapping m/z windows-by using selected ion monitoring (SIM) scan mode for the Thermo Scientific FT-ICR and Orbitrap series-and then 'stitching' these windows together to create a complete mass spectrum. The AGC target value does not need to be set as high for narrower m/z windows (with fewer detectable features) as compared with a full-scan spectrum to achieve similar peak detection sensitivity. Overall, this approach increases the dynamic range and detection sensitivity while retaining high mass accuracy by minimizing space-charge effects that would arise from high AGC settings ( Fig. 2; Table 1 ) 23, 24 .
The spectral-stitching method was optimized for the FT-ICR, Q Exactive and Orbitrap Elite DIMS by determining the highest AGC setting (i.e., highest sensitivity) that retains high mass accuracy; by establishing the m/z window width for maximal peak detection; and by calculating the minimum number of scans for reliable and reproducible peak detection. Detector sensitivity at each end of the individual narrow m/z windows was found to be lower than across the majority of each m/z range, and thus it was characterized to establish the usable high-sensitivity region of each m/z window that was retained (and hence determine the overlap of the m/z windows that was required in the method to prevent signal loss). Before applying this method, optimization of the biological sample concentration is strongly advised, in order to prevent poor nESI stability, poor RSD values of the peak intensities from samples that are too concentrated and poor detection sensitivity for those samples that are not sufficiently concentrated.
Data processing
Before data processing, DIMS spectra should be viewed using the vendor's software to identify any analyses for which the electrospray failed during acquisition; such analyses should be removed. DIMS data on both the FT-ICR and Orbitrap platforms are recorded as transient (time domain) files and as triplicate technical analyses 23, 24 (Fig. 1) ; for some mass spectrometers, time domain data are available to the analyst only as a single preprocessed vendor-encoded file (a .raw file, in the case of Thermo Scientific), whereas for other spectrometers the data are available in their rawest form as multiple transient data files. For this latter case (for Bruker and Thermo Scientific FT-ICR MS instruments), data processing includes averaging of the transient data, Hanning apodization and zero-filling, followed by Fourier transformation to convert time into the frequency domain using custom-written Matlab code 23, 24, 57 . From this point, data processing is consistent across all DIMS approaches described in this protocol (Fig. 1) . To remove obvious noise features from the data, any peaks with a signal-to-noise ratio (SNR) threshold of less than (typically) 3:1 are removed. Data are then mass calibrated to convert from the frequency domain into m/z values, using a calibration equation (for the FT-ICR, Thermo Scientific instruments use m/z = (A/f ) + (B/f 2) 23, 56 ; f is the frequency (KhZ); A and B are calibration parameters from the instrument). External calibration uses the calibration parameters derived from the periodic calibration of the mass spectrometer using a defined sample of known standards. Postacquisition internal calibration is used to increase the mass accuracy in each window by using the accurate masses of metabolites known to be present in the mass spectra of the biological samples. Finally, the multiple narrow m/z windows are stitched together into one continuous m/z spectrum using custom-written Matlab code.
To identify genuine peaks and to remove noise features within the mass spectrum of each biological sample, only peaks that are present in at least two out of three of the technical replicate analyses of the sample are retained (termed 'replicate filtering'). Contaminate peaks arising from the extraction method are flagged by comparing the biological sample spectra with the extract blank, and are then removed if their intensity in the sample is less than three times that of the extract blank (termed 'blank filtering'). The m/z data from multiple biological samples are combined into a single data matrix with samples as rows and m/z features as columns. Peaks are retained if they are present in a given percentage of samples defined by the user (termed 'sample filtering')-e.g., 100% for the calculation of normalization quotients (see below); >80% as a default setting to achieve robust sample filtering 57 ; and lower-percentage filtering in the case in which multiple classes exist in the data set and peaks within a single class need to be retained. Note that the lower the sample filter target percentage, the greater the number of missing values that will be created in the data set. At this point, the number of peaks within each biological sample is assessed, and those with abnormally high numbers of missing values are deemed technically poor and removed using 'missing-value filtering' (see 'Data QC' section, below). Before statistical analysis, several data preprocessing steps are required. As a first step, data matrices are normalized by the probabilistic quotient normalization (PQN) approach to remove the variation caused by unequal amounts of detectable metabolites in each of the biological samples 58 . For studies in which the analytical measurements are made across several batches, the intensity measurements of QC peaks in different batches are normalized to correct the technical variation arising from inter-batch measurements using a signal correction method 59 . This approach can also be used to correct signal-intensity technical variation that arises within a single batch. The signal correction method requires QC samples to be acquired at regular intervals throughout the analytical run. Next, the RSD values of the intensities of each spectral peak are assessed within the QC samples 44 , and any peaks with unacceptably high RSD values are deemed unreliable measurements and removed using the 'peak quality filter' (see 'Data QC' section, below). Missing values are now imputed into the normalized DIMS data matrices. Missing values generally occur because (i) the metabolite is not present or (ii) the instrument fails to detect a metabolite that was present. As missing values can be problematic for statistical analyses, they are typically imputed using the K-nearest-neighbor method (KNN), which has been demonstrated to be the most suitable for DIMS data 60 . However, in cases in which the user deems missing values to arise from genuinely missing metabolites, they may choose to omit this step. Before analysis of multivariate statistics, a generalized log transformation is optimized (for each specific data set using the QC sample data) and applied to stabilize the technical variance and reduce the dominance of the highly intense and variable peaks in the multivariate statistics 61, 62 .
Data quality control
In summary, seven filtering steps are applied in the pipeline to ensure high data quality:
(i) if the nESI spray current fails during data collection on the mass spectrometer, the affected analyses are manually discarded; (ii) for peaks to be considered actual detected features, they must be observed in at least two DIMS measurements of the biological sample (termed 'replicate filtering', see above and Step 20); (iii) only peaks occurring at more than three times higher intensity in the biological samples relative to the blank samples are retained in the data set (termed 'blank filtering', see above and
Step 23); (iv) all peaks retained in the data set occur in the majority of biological samples measured in the study (termed 'sample filtering', see above and Step 24); (v) all biological samples have a relatively consistent number of peaks (termed 'missing-value filtering' , see above and Step 25); (vi) any batch effects or temporal drifts in peak intensity, assessed on a peak-by-peak basis using the QC samples, are corrected for (termed 'signal correction', see above and Step 28); (vii) the reproducibility of peak intensities is calculated within the QC samples across the data set on a peakby-peak basis. Nonreproducibly measured peaks are excluded (termed 'peak quality filter', see Step 28) .
Univariate and multivariate statistical analysis
Nontargeted nESI DIMS metabolomics and lipidomics studies aim to measure the variation and covariation of metabolite or lipid abundances between or across biological sample groups in order to generate new hypotheses for subsequent targeted investigation. Explorative analysis using unsupervised multivariate statistical methods (e.g., principal components analysis, PCA) is carried out first to assess the data reproducibility, detect possible outliers and visualize possible groupings in the data set. Subsequently, a univariate statistical test is applied to each peak in the nESI DIMS data to identify specific peaks whose intensities significantly change across different biological sample groups. These tests can be parametric (assuming a normal distributione.g., t-test or ANOVA) or nonparametric (e.g., Wilcoxon signedrank or Kruskal-Wallis test). Because of the large number of peaks that are often analyzed (and statistically tested), a multiple testing procedure is carried out to reduce the occurrence of peaks incorrectly being identified as significant (i.e., to reduce false positives). The optimal approach for DIMS data is to apply the Benjamini-Hochberg false-discovery rate procedure 63 . A disadvantage of univariate tests is that possible correlations between peaks are not taken into account. Therefore, supervised multivariate approaches (e.g., partial least squares discriminant analysis, PLS-DA) are used as a complementary approach to discover individual metabolites or groups of metabolites that discriminate between different biological sample groups. Note that these models can be used to predict the class (i.e., healthy or diseased) of any subsequent biological samples. The prediction accuracy, based on internal cross-validation of the data or an independent test set, is used as a measure of the group separation. Statistical significance of the observed group separation is evaluated with permutation testing. In a permutation test, the labels of the biological samples are randomly permuted and a new PLS-DA model is constructed. This process is repeated a thousand (or more) times. Statistical significance of the original PLS-DA model is then assessed by relating the values of the group separation of the permutated data to those of the nonpermuted data. Although the permutation test is a powerful statistical procedure, its results should be approached cautiously for very small sample sizes ('Experimental design') 64, 65 . Peaks that contribute to the group separation are identified based on PLS-DA variable importance measures such as the variable importance in the projection (VIP) or the selectivity ratio (SR). To reduce the influence of irrelevant peaks on the model, forward (variable) selection that is based on the VIP or SR can be carried out before permutation testing.
Metabolite annotation
Automated and robust annotation and identification of hundreds to thousands of peaks in MS-based metabolomics is currently a difficult, complex process and is widely regarded as a bottleneck of data interpretation 66 . Analytical and computational developments are, however, continuing to improve this procedure. Metabolite annotation in spectral-stitching DIMS studies starts by assigning elemental compositions to all (or as many as possible) m/z measurements, followed by mapping each elemental composition to a single or multiple chemical name(s). This is done using in-house-developed MI-Pack software situated within Galaxy that interacts with public databases (e.g., Human Metabolome Database (HMDB), Kyoto Encyclopedia of Genes and Genomes (KEGG), LIPID MAPS and PubChem) 67 . Because of the finite mass accuracy of mass spectrometers and the complexity of chemical space, this process often results in multiple annotations per peak; however, the ultra-high mass accuracy used here minimizes the number of annotations. To further reduce the number of false-positive assignments, we use several approaches 67, 68 : a single metabolite is often detected as multiple metabolic features, including adducts (e.g., [M+H] + and [M+Na] + ) and naturally occurring isotopes. The latter are often used to reduce the number of incorrect elemental compositions using relative isotopic abundance measurements to calculate the number of atoms (e.g., carbon, sulfur and nitrogen) within the metabolite 24 .
To categorize the confidence of metabolite identification and to make metabolite assignments within a study or across multiple studies comparable, different levels of metabolite annotation and identification have been reported and described by the Metabolomics Standards Initiative (MSI) 27 . Metabolite assignments in nESI DIMS experiments are based upon m/z values and therefore are reported as putatively annotated (defined as level 2 by the MSI); however, the ultra-high mass accuracy and additional steps used in our DIMS workflow (e.g., the use of adduct and isotope patterns) result in a high degree of confidence in the molecular formula(e) annotations. Additional targeted experiments, such as MS n fragmentation and spectral library matching against an authentic standard, are required to definitively identify the compound(s) of interest (defined as level 1 by MSI).
Data storage and sharing
Metabolomic studies continue to increase in size and produce ever-increasing amounts of experimental data. Open access to research data and knowledge, in a standardized and reproducible way, is important for maximizing the value of metabolomics (or any other) data sets. As the requirements of journal publishers (including data journals such as Scientific Data and Gigascience) and funding bodies to share data and results continue to grow, it is likely and indeed highly preferable that open access to data will become standard practice in metabolomics. This is supported by the increasing number of publicly available repositories for experimental data (e.g. MetaboLights and Metabolomics Workbench 69, 70 ), as well as the number of metabolomics data sets within these public repositories. Recently, a data descriptor for a spectral-stitching nESI DIMS metabolomics study-in which the efficacy of a signal-correction algorithm and the reproducibility of a multibatch study were evaluated-was published in such a data journal, and the data are openly available via the MetaboLights repository (MTBLS79; ref. 69) . This data set serves as a benchmark for the metabolomics community and complements the current publication 29 . EQUIPMENT SETUP Equipment used during extraction Precool both the swinging-bucket and fixed-angle microtube centrifuges to 4 °C. Turn on the Precellys 24 homogenizer to allow it to initiate. Turn on the cold trap that is connected to the SpeedVac concentrator before starting the extraction procedure (requires ~2 h to achieve operating temperature).
MaterIals
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• • • • • • • • • • • • • • • • • • • • • • • • •being tested, samples (including tissue or biofluids-e.g., plasma, serum and urine
Establishing Galaxy-M workflows
The data processing and analysis steps described here are collated into Galaxy-specific tools and workflows, referred to as Galaxy-M 28 . An extensive guide for how to install Galaxy-M is available from GitHub (https://github.com/Viant-Metabolomics/Galaxy-M).
Here, tools and workflows within Galaxy-M are well documented, including default parameters, and they have self-explanatory names to guide the user through the data processing and analysis steps. Additional reading and tutorials on how to use a Galaxy instance are available online (https://wiki.galaxyproject.org/Learn). Most DIMS studies include a large number of files and a considerable amount of data. Galaxy-M assumes that the user will store the data (e.g., .raw files with or without transient data) on a file system that is directly accessible by the Galaxy instance (i.e., no Galaxy-upload required).
proceDure Metabolite and lipid extraction from biological samples • tIMInG 2-4 h per batch
 crItIcal To minimize inconsistencies across the handling of biological samples and therefore to reduce sample-to-sample variation, extract no more than 20 samples in a single batch. Repeat this section until all samples are extracted.  crItIcal Randomize the extraction order to ensure that biological sample classes are randomized within and across extraction batches.  crItIcal An 'extract blank' sample must be prepared. Here, the extraction procedure is carried out in the absence of a biological sample, and the resulting extract blank is used to identify compounds that arise solely from sample preparation procedures. 1| Perform the steps in option A if you are extracting from tissue, whole organisms or mammalian cells. Perform the steps in option B if you are extracting from biological fluids. (a) extraction from tissue, whole organisms or mammalian cells (i) Weigh the biological samples, ensuring that they do not thaw by keeping them on dry ice. Mammalian cell biomass should be estimated during the quenching step (see Reagent Setup-Biological sample collection and handling, above). (ii) For tissues or whole organisms, place the biological material into a labeled Precellys 24 tube and set it on dry ice.
For mammalian cells, place the biological material into a labeled high-quality 2-ml microcentrifuge tube and set it on dry ice. (iii) Add 8 µl of ice-cold methanol for each milligram of frozen biological sample mass (8 µl/mg; using high-quality solvent-resistant plastic pipette tips). (iv) For tissues or whole organisms, homogenize the samples using a Precellys 24 system (2 × 10-s bursts of 6,400 r.p.m. (ix) Centrifuge the samples (2,500g, 4 °C, 10 min) using a swinging-bucket centrifuge to induce phase separation.  crItIcal step Remove the samples from the centrifuge bucket extremely carefully to avoid disturbing the protein interface and biphasic separation of solvents. (x) Set the samples on the bench at room temperature and allow them to sit for 5 min to allow completion of the phase separation. The sample is now biphasic, with the polar (upper) and nonpolar (lower) layers separated by an interface of denatured proteins and cell debris. (xi) Remove a fixed volume (typically 300 µl, with the option to collect multiple aliquots) of the polar phase and add it to a high-quality 1.5-ml microcentrifuge tube using a clean Hamilton syringe. Rinse the syringe twice with methanol wash solvent (2 × 500 µl) between biological samples. (xii) Remove a fixed volume (typically 150 µl, with the option to collect multiple aliquots) of the nonpolar phase and add it to a new 1.75-ml glass vial tube using a clean Hamilton syringe. Rinse the syringe twice with chloroform wash solvent (2 × 500 µl) between biological samples. To obtain the nonpolar phase, slide the Hamilton syringe down the side of the glass vial and gently move the protein interface out of the way with the syringe.  crItIcal step Removing the nonpolar layer requires care so as to avoid attachment of debris to the Hamilton syringe. (xiii) Dry the polar extracts in a SpeedVac concentrator using no heat (1-2 h) .
! cautIon Ensure that the associated cold trap has reached operating temperature (<−100 °C) in order to prevent solvents from being vented into the atmosphere. (xiv) Dry nonpolar biological samples under a stream of nitrogen (using the nitrogen sample concentrator; 15 min), and cap the vials quickly to ensure that a nitrogen-rich atmosphere remains inside. ! cautIon This must be done in a fume hood to prevent the escape of chloroform into the laboratory.  crItIcal step This removes oxygen from the sample to prevent lipid oxidation and peroxidation. (xv) Store dried extracts frozen at −80 °C or proceed to Step 2.
 pause poInt Extracted biological samples can be stored at −80 °C for up to a few months.  pause poInt Extracted biological samples can be stored at −80 °C for up to a few months.
resuspension of biological sample extracts in DIMs solvent
• tIMInG 1-2 h  crItIcal Before biological sample resuspension, it is advisable to create and analyze a serial dilution of resuspended extracts to establish the optimal concentration, which maximizes peak counts (of biological origin) and stability of the nESI current for the specific biological samples being analyzed. Recommended starting points for the resuspension solvents (which include sample modifiers, formic acid and ammonium acetate, to enhance electrospray efficiency) and volumes are detailed in table 2. This is carried out using a spare biological extract, which will be used up and not form part of the subsequent metabolomics analyses. 2| Add the appropriate type and volume of DIMS solvent to the extracts as described in table 2 (or the volume determined in the method optimization experiment) and vortex (30 s) to dissolve.  crItIcal step Lipid concentrations should not exceed 10 pmol/µl in order to prevent the formation of lipid aggregates 34 .
3| Create a QC sample by taking a fixed volume from each biological sample and pooling, to a minimum total volume of 180 µl (enough for six QC analyses). As the number of biological samples analyzed increases, so should the minimum QC volume, such that a QC sample can be analyzed every 4-6 biological samples throughout an analytical run.  crItIcal step If data will be collected in several batches, an identical QC sample must be used across all batches. This will allow successful application of the signal correction algorithm (Step 28).
4|
Centrifuge the samples (polar extracts in microcentrifuge tubes: fixed-angle rotor, 20,000g, 4 °C, 10 min; nonpolar extracts in glass vials: bucket rotor, 2,500g, 4 °C, 10 min) to remove particulates that can adversely affect nESI stability.  crItIcal step Particulates in the sample can fully or partially block the nESI nozzle, leading to loss or instability of electrospray.
5|
When loading samples, place a 96-well or 384-well plate on wet ice (to prevent sample evaporation) and pipette 3 × 10 µl of each sample into triplicate (consecutive) wells along a row, using either Fisherbrand tips (polar) or carbon tips (nonpolar). Upon completion of each well-plate row, cover with self-adhesive aluminum sealing tape to prevent solvent evaporation.  crItIcal step To avoid particulates in the sample wells, keep the samples at the same fixed angle as they were in the centrifuge and avoid disrupting the pellet (probably invisible to human eye) when pipetting.  crItIcal step Ensure that the biological sample phenotypes are randomized in the well plate (facilitating a randomization of the analytical run order). Ideally, the sample order should start with a series of trial samples, typically MS diluent (×3 technical replicates) and QC samples (×3 technical replicates), which allows the user to assess the quality of the electrospray and DIMS detection. This is followed by the extract blank sample (×3 technical replicates) and by a QC sample (×3), and then by the biological samples (×3 each) with a QC sample (×3) every 4-6 samples, ending with a QC sample (×3; see Fig. 3 for an example). The analysis of QC samples at regular intervals throughout the sample sequence run is essential to enable signal correction data processing (Step 28).
6| Once completed, remove the self-adhesive aluminum sealing tape and heat-seal the entire well plate with the appropriate foil (170 °C for 2 s).
7|
Open the ChipSoft software (controlling the TriVersa NanoMate) and in 'Interface Settings' set the plate cooler to 10 °C. Put the well plate on to the TriVersa NanoMate and allow at least 30 min for the samples to equilibrate to 10 °C.  crItIcal step Variations in sample temperature can alter the electrospray process, leading to poor technical reproducibility.
DIMs analysis
• tIMInG ~9 min per polar biological sample, comprising triplicate technical replicate analysis on the Q exactive, orbitrap elite or ltQ Ft ultra, and including sample loading and equilibration 8| Ensure that the well plate is located on the TriVersa NanoMate and has been cooled to 10 °C. Load a new electrospray chip and 384-tip tray into the TriVersa NanoMate and empty the tip waste tray. Align the TriVersa NanoMate with the MS source (box 1). Within the ChipSoft software (in 'Sequence View'), create a sample sequence using the optimal TriVersa NanoMate method (box 1).  crItIcal step Ensure that the TriVersa NanoMate contact closure setting is set to 'Trigger acquisition when Input Signal received', which enables the TriVersa NanoMate to initiate MS data collection when the nESI begins.
9|
Within the MS vendor software (Xcalibur, for Thermo Scientific instruments), create a sample run order using the method created in box 1 (see supplementary Methods 1 and 2 for recommended mass spectrometry methods).  crItIcal step For FT-ICR instruments, ensure that the collection of time domain (transient) data is enabled (within the Tune program: 'Diagnostics' → 'Toggles' → 'Include FT transient'). Data processing: spectral-stitching and signal filtering • tIMInG 6-12 h, depending on the number of biological samples  crItIcal At any point in the data analysis process, the Galaxy history can be downloaded, archived and shared with others. 11| Create a text file (as comma-separated value (.csv) format, e.g. 'samples.csv') to function as a sample identifier for the samples being processed. This contains four columns separated with a comma: first column-spectral file names; second column-class identification (e.g. control, QC); third column-batch number; and fourth column-run order.
12|
Open an Internet browser and go to the Galaxy-M homepage (e.g., http://localhost:8080 for a local Galaxy instance; see 'Establishing Galaxy-M-workflows' in Equipment Setup, above). 16| Run 'Tools' → 'SIM-stitching' → 'Sum Transients' . This sums the transient data for the mass spectral SIM windows within each technical replicate. To avoid the inclusion of low-quality transients (caused by poor or unstable nESI), a total ion current threshold can be set (optional). Transients are removed according this threshold.
17| Run 'Tools' → 'SIM-stitching' → 'Process Transients' . This applies Hanning apodization, zero-filling, fast Fourier transform and baseline correction to the summed transients.
18| (Optional) Create a tab-separated text file (.txt format; e.g., 'calibrants.txt') that will enable internal mass calibration of the spectra. This file contains the names (in the first column) and the exact mass (in column 2) of compounds known to be present in the sample. If this information is not known, this step can be omitted and the data will be externally calibrated (almost certainly resulting in lower mass accuracy).  crItIcal step To create a true calibrant list, additional MS experiments (e.g., fragmentation) are often needed to annotate (i.e., elemental composition) and/or identify (i.e., structure) the m/z values. Compounds detected in the extract blank sample can be used for calibration across different MS studies when identical extraction protocols and instruments have been used.
19|
Run 'Tools' → 'SIM-stitching' → 'Mass Calibration and SIM-stitching' . This stitches the multiple m/z windows together (removing any m/z overlap in the process) and internally calibrates the m/z axis of the spectra (optional). The required noise threshold, as a SNR, must be stipulated (typically 3:1; data with intensities below this threshold will be discarded). Figure 3 | Recommended arrangement of samples in a 96-well plate for a spectral-stitching nESI DIMS experiment. Samples are each loaded as triplicates and are analyzed in the order they appear in the plate (e.g., position A1, A2, A3, …., H12). The plate begins with six 'trial' samples (A1-A6, typically 3× DIMS solvent (DS T ) and 3× QC samples (QC T )) that are used to check the nanoelectrospray stability of the DIMS system and the QC samples. This is followed by 3× extract blank (EB) samples. QC samples are injected after the EB, and then after every four to six biological samples, and at the end of the plate. Biological samples (BSs) across different sample classes (typically different biological phenotypes; shaded green and blue) are placed in a random order across the plate to minimize possible biases resulting from analysis order.
Box 1 | TriVersa NanoMate and mass spectrometer setup.
• tIMInG 1 h (a) Initial system setup 1. If the mass spectrometer has been in standby mode, allow at least 2 h to equilibrate once it is fully switched on. 2. Open the MS acquisition viewer on the PC (MS Tune for Thermo systems). Calibrate the MS according to the manufacturer's instructions using the calibration mixture. 3. Attach the TriVersa NanoMate onto the bracket on the front of the MS. 4. Load the 400-nozzle nESI chip, 400 tip set and a 96-well plate containing a test biological sample (e.g., biological extract in MS solvent, table 2). 5. Ensure that the nitrogen cylinder (or generator) supplying the TriVersa NanoMate has sufficient gas remaining (recommended to have >1,000 p.s.i. for a 24 h run) and has sufficient back-pressure. To optimize the nanoelectrospray and DIMS detection for each specific biological sample, type inject a test sample by using the 'Spray Optimization' tool (within the 'Method Manager' tab). The TriVersa NanoMate electrospray current should be stable and between 100 and 300 nA (for problems see table 3 ).  crItIcal A stable electrospray current is required to generate reproducible data. Electrospray stability is partially dependent on the voltage and gas pressure settings on the TriVersa NanoMate (recommended settings above). These settings are sample type dependent and therefore may require optimization to improve electrospray stability. 3. Optimize the TriVersa NanoMate voltage: set the gas pressure to 0.3 p.s.i. and the voltage to 1.5 kV, and then-while monitoring the spray stability on the mass spectrometer-decrease the voltage in steps of 0.1 kV until the spray is lost. Switch the polarity mode on the TriVersa NanoMate and then switch back to the polarity that was originally being used. If the spray does not return, add 0.2 kV to the current voltage setting and this is now the optimal voltage setting that should be used. 4. Optimize the TriVersa NanoMate pressure: set the voltage to its optimized setting and the pressure to 0.3 p.s.i. Then alter the pressure in steps of 0.05 p.s.i. and observe any improvement or deterioration of the electrospray current. 5. Optimize the position of the TriVersa NanoMate in relation to the MS source: observe the ion intensity and reproducibility in the mass spectrometer using the mass spectrometer detector program (MS Tune). Move the TriVersa NanoMate closer or further away from the mass spectrometry source (by changing settings in Method Manager/Spray Optimisation). To increase the sensitivity, move the TriVersa NanoMate closer to the MS, and to increase reproducibility move it further away (the optimal distance should be in the range 3-5 mm). For problems with DIMS detection, see table 3. 6. Where available, it is recommended to optimize peak detection sensitivity by using the automated tuning function (within the mass spectrometer detector program, MS Tune) on ions within the mass ranges of interest-e.g., ions ~75 m/z ('low tune'), 150 m/z ('medium tune') and 400 m/z ('high tune') for polar extracts. Each m/z range optimization is carried out independently by repeating the tuning at that m/z until no further increase to signal intensity is achieved, and then saving the optimal tune parameters as separate tune files (i.e., 'low tune', 'medium tune' and 'high tune'). If internal calibration is required, provide 'calibrants.txt' (Step 18) and specify the minimum intensity (typically >50 SNR) and the maximum mass tolerance (typically 2.0 ppm) of peaks to be used for internal calibration.
20| Run 'Tools' → 'SIM-stitching' → 'Replicate Filter' . This step retains peaks present within at least 2 of the triplicate measurements of each biological sample (and averages their intensities) and thus functions to remove noise features.
The maximum m/z ppm range a peak must fall within (across the triplicate measurements) for it to be counted as the same peak must be stipulated (typically 1.5 ppm).  crItIcal step If the mass accuracy of the data is less than optimal, this m/z tolerance can be increased to ensure that real peaks are retained).
21| Run 'Tools' → 'SIM-stitching' → 'Align Samples' . This aligns the peaks across all the 'Replicate Filtered' biological samples. The maximum m/z ppm range a peak must fall within (across the biological samples) for it to be counted as the same peak must be stipulated (typically 2.5 ppm).  crItIcal step If the mass accuracy of the data is less than optimal, this m/z tolerance can be increased to ensure that sample-related peaks are retained.
22| Run 'Tools' → 'SIM-stitching' → 'Create DSO' . This converts the DIMS data into a DataSet Object (DSO-a construct of Eigenvector Research to facilitate data set handling and sharing (http://www.eigenvector.com/software/dataset.htm)) .xml file, which includes a peak intensity data matrix, row labels (sample classes), column labels (m/z values) and information provided in the text file in Step 11. The data within the DSO are updated with each additional processing step.
23| Run 'Tools' → 'SIM-stitching' → 'Blank filter' . This compares biological sample peaks with those appearing in the 'extract blank sample' . Peaks that appear in both are discarded according to the defined biological:blank peak intensity ratio (typically, peaks are retained if this ratio is >3). 27| (Optional) Run 'Tools' → 'Matrix Processing' → 'Peak Outlier Detection' . This tool detects outliers detrimental to the effectiveness of the signal-intensity correction in Step 28. For each peak, it fits a second-or third-order polynomial regression curve to the non-QC peaks when samples are ordered by injection. Only non-QC data points are used in this curve fitting, in order to avoid statistical bias. A confidence interval for each curve is calculated (typically 95 or 99%) and any (QC) data point lying outside the confidence interval is considered an outlier, and can be removed 59 .
28| (Optional) For single-or multiple-batch studies, the signal intensity correction tool can be applied. Run 'Tools' → 'Matrix Processing' → 'Signal Correction and Peak Quality Filtering' . For each peak, the tool applies robust cubic smoothing splines to the QC data points ordered by injection. The resulting fitting curves are then used to correct for the technical variation arising from interbatch measurements 59 . This approach can also be used to correct technical variation in signal intensity that arises within a single batch. In addition, peaks that are highly variable across batches can be filtered based on different criteria (e.g., RSD >30%).
29| Run 'Tools' → 'Matrix Processing' → 'Missing Value Imputation' . This step uses the KNN method to impute any values that are missing from the normalized data matrix. K can be set by the user (default is 5).
30| (This step is required only when calculating multivariate statistics.) Run 'Tools' → 'Matrix Processing' → 'G-log Transformation' . This optimizes the lambda parameter from the QC data matrix (i.e., QC samples within the data matrix are automatically selected), and then applies the generalized log transformation to the normalized data matrix.
statistics analyses • tIMInG 1-2 h 31| Univariate statistical analysis can be applied to the normalized data matrix immediately before missing value imputation (from Step 28) or after missing value imputation (from Step 29) . Run 'Tools' → 'Statistics' → 'Univariate Analysis', or export the data for further analysis using external statistical packages ('Tools' → 'DataSet Object').
32|
Multivariate statistical analysis can be applied to the generalized log-transformed normalized data matrix (from Step 30) . Run 'Tools' → 'Statistics' → 'PCA and Scores Test', or export the data for further analysis using external statistical packages ('Tools' → 'DataSet Object').
Metabolite annotation • tIMInG 1 h, and substantially longer, >8 h, when 'Molecular Formulae search' is used 33| Run 'Tools' → 'DataSet Object' → 'Get Peak List' to create a peak list from the biological sample data matrix (Step 25). 37| Run 'Tools' → 'MI Pack' → 'Combine Outputs' . This produces a summary file of the outputs produced by Steps 33-36.
34|
Depositing of data from metabolomics studies into public repositories • tIMInG variable 38|
We recommend that all the DIMS data, including .raw files and data matrices, be deposited into a public repository (i.e., MetaboLights 69 (http://www.ebi.ac.uk/metabolights) and/or Metabolomics Workbench 70 (http://www. metabolomicsworkbench.org)). To do this, follow the instructions on the data repository's website. A stable identifier will be assigned to the data set, which can then be used to cite the data set in a publication.
? troublesHootInG Troubleshooting advice can be found in table 3. Step 38, depositing of data from metabolomics studies into public repositories: variable box 1, TriVersa NanoMate and mass spectrometer setup: 1 h
antIcIpateD results
The spectral-stitching nESI metabolomics/lipidomics method-in which data are collected as a series of overlapping m/z windows that are 'stitched' together ( Fig. 2) -generates high-quality data in less than 10 min per biological sample (including sample loading and equilibration, and triplicate sample acquisition; table 1). This approach substantially increases the dynamic range of the spectrum (Fig. 4) 23, 24 without increasing the number of ions entering the detector, which could lead to space-charge effects and poor mass accuracy 56 . The number of detected peaks increased more than fivefold as compared with a single wide-scan m/z collection (Fig. 4) 23, 24 . The use of nESI is critical because it lowers ionization suppression as compared with standard ESI, which also enhances peak detection 25 . Detection sensitivity is further increased by applying the method on an instrument with a physically larger detector that allows more ions to enter without increasing space-charge effects: a threefold increase in peak detection was observed on the LTQ FT Ultra, with larger detector as compared with that of the LTQ FT 24 . For each type and size of MS detector, the spectral-stitching method, including m/z window width, should be optimized to maximize the number of peaks detected (table 1) . The mass accuracy of data generated by the spectral-stitching nESI method on the FT-ICR MS is ±1 ppm for peaks >600 m/z 23, 24 . Collecting the data as multiple m/z windows aids the internal mass calibration because each window's m/z range can be shifted independently of the others' . The ultra-high mass accuracy achieved by this method enables molecular formula(e) annotation of peaks and allows the assignment of putative metabolite and lipid names. Expected numbers of detected and annotated metabolite and/or lipid features vary, depending on sample type. Negative ion spectral-stitching nESI metabolomics of ca. 1 mg of Daphnia pulex-pulicaria detected and putatively annotated 1,973 and 369 peaks (± 1.5 ppm mass tolerance), respectively, whereas negative ion lipidomics of ca. 10 7 (ca. 10 mg) human leukemia cells detected and putatively annotated 2,934 and 898 peaks (± 2 ppm tolerance), respectively. A lipid spectrum in which selected peaks have been annotated is shown in Figure 5 .
The spectral-stitching nESI DIMS method demonstrated high analytical reproducibility: median peak intensity RSD measurements across the QC samples were ~8% for both the LTQ FT and the LTQ FT Ultra, ~13.5% for the (LTQ) Orbitrap Elite and ~16% for the Q Exactive (table 4). These results suggest that nESI DIMS using a hybrid instrument with a linear ion trap (i.e., LTQ) yields more-reproducible peak intensities. These levels of reproducibility have been shown to be maintained in large-scale studies in which data were collected over several days. For example, PCA of a large D. pulex-pulicaria metabolomics study showed highly reproducible QC samples that were tightly clustered on the PCA scores plot ( Fig. 6; ref. 72 ). Such low technical variance enabled biological variance to be visualized, with a clear distinction of the metabolomes of F0 and F1 D. pulex-pulicaria generations ( Fig. 6; ref. 72 ). When the spectral-stitching nESI DIMS method was used for lipidomics, reliable and meaningful biological information for identifying drug-induced lipid changes in leukemia cells was generated 7 . Metabolite-intensity measurements were shown to be robust and comparable to those made by NMR spectroscopy-i.e., tyrosine-, creatine-and phosphocreatine-intensity measurements derived from the same sample by the two analytical methods were strongly correlated ( Fig. 7; ref. 11) . A more extensive comparison of the spectral-stitching nESI DIMS and NMR approaches recently showed that the DIMS approach is capable of relative quantification comparable to NMR for several metabolites 30 . NMR spectroscopy is a quantitative technique that is well established in the field of metabolomics, which in turn demonstrates the robustness of the spectral-stitching method.
To conclude, the spectral-stitching nESI DIMS method is reproducible, sensitive and of high throughput, with ultra-high mass accuracy. These attributes make it an ideal tool for rapid and large-scale metabolomics or lipidomics analyses to identify phenotype-induced perturbations to the metabolome or lipidome. 
